On July 16, 2020, the Release Conference of IP and Financial Support for Scientific and Technological Development Achievements was held at Pingshan Yanzihu International Exhibition Center and the Chinese First Biological Pharmaceutical Industry IP Securitization Product was successfully approved, marking the official landing of the Chinese First IPR Securitization Products focusing on biological medicine professional fields and providing a new model for solving the pain points of financing for small and medium-sized enterprises, fundamentally enhancing the impetus of enterprises for scientific and technological innovation and creatively expanding the channels of government support policies.

The current "Phase 1 to Phase 10 Special Scheme for IP Asset Support of Pingshan District – Southern Center – Yangtze River" has been approved for issuance in SZSE in the form of shelf offering, and more than 10 biomedical enterprises in Pingshan District will be benefit from the first phase of RMB100 million financing.